Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG39186

DNAJC10 Knockout K562 Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Pleural effusion

  • Disease:

    Chronic myeloid leukemia

The DNAJC10 Knockout K-562 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population derived from the K-562 chronic myelogenous leukemia cell line. Disruption of the DNAJC10 gene eliminates the critical ER co-chaperone ERdj5, impairing ER-associated degradation (ERAD) and activating the unfolded protein response. This model provides a powerful tool to dissect DNAJC10??s role in hematopoietic cell stress responses. DNAJC10 normally interacts with BiP/GRP78 and the SEL1L-HRD1 complex to reduce misfolded protein disulfide bonds and facilitate proteasomal degradation. This loss-of-function model is ideal for investigating ER stress biology in leukemia, evaluating chemosensitivity to ER stress-inducing agents, and studying protein homeostasis. Applications include Western blotting for ER stress markers, flow cytometric apoptosis assays, and co-immunoprecipitation of ERAD components. For more information, contact Ascent Research.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    K562

    Sex of Donor

    Female

    Derived From Site

    In situ; Pleural effusion

    Gene Name

    DNAJC10

    Gene Identifier

    NCBI Gene ID 54431

    Growth Mode

    Suspension

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    RPMI 1640

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The DNAJC10 Knockout K-562 Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal knockout cell population in which the DNAJC10 gene has been disrupted in the human K-562 chronic myelogenous leukemia cell line. This product provides a powerful loss-of-function model for investigating the role of the endoplasmic reticulum co-chaperone DNAJC10 (ERdj5) in protein homeostasis and ER stress signaling. The polyclonal format offers a heterogeneous knockout cell pool, suitable for functional studies without clonal selection artifacts.

The host K-562 cell line, derived from the pleural effusion of a CML patient in blast crisis, is a pluripotent hematopoietic progenitor capable of multi-lineage differentiation. It is widely used to study leukemia biology, drug sensitivity, and apoptotic signaling, and serves as a relevant model for investigating oncogenic drivers and stress response pathways in chronic myelogenous leukemia. The cells grow robustly in suspension, facilitating high-throughput screening and detailed mechanistic studies.

DNAJC10 encodes an ER-resident oxidoreductase that reduces disulfide bonds in misfolded glycoproteins to promote ER-associated degradation (ERAD). It acts downstream of ER stress sensors IRE1??, PERK, and ATF6, and is transcriptionally regulated by XBP1 and ATF6. DNAJC10 interacts with key ERAD components including BiP/GRP78, EDEM1, OS9, and the SEL1L-HRD1 complex, facilitating retrotranslocation, ubiquitination, and proteasomal degradation via p97/VCP. Loss of DNAJC10 disrupts ERAD, activating the unfolded protein response (UPR) and altering cell fate under proteotoxic stress.

In K-562 leukemia cells, which often exhibit elevated basal ER stress, DNAJC10 knockout provides a model to study the dependency of leukemogenesis on ERAD. Disruption of DNAJC10 may sensitize these cells to ER stress-inducing agents such as tunicamycin, uncovering potential therapeutic vulnerabilities. This system allows dissection of ER proteostasis and apoptosis regulation in hematologic malignancies.

These polyclonal knockout cells are suitable for Western blot monitoring of ER stress markers (BiP, CHOP), qRT-PCR analysis of XBP1 splicing, and flow cytometric apoptosis assays (Annexin V). Co-immunoprecipitation studies can characterize interactions with ERAD machinery, while proteasomal activity and ubiquitination profiling reveal functional consequences. Cell viability assays (MTT) with ER stressors assess chemosensitivity. These assays help delineate DNAJC10??s role in ER stress and drug response. For further details, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)